SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US OTC > Cannabis > OWC Pharmaceutical Research Corp. (OWCP)

Thats a powerful statement from someone with her

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
MMMQA Member Profile
Member Level 
Followed By 157
Posts 2,595
Boards Moderated 0
Alias Born 12/28/12
160x600 placeholder
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 6/22/2017 1:44:13 PM
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 6/22/2017 1:30:15 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 6/21/2017 4:38:40 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 6/21/2017 4:16:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/15/2017 6:04:02 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/8/2017 6:04:20 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/30/2017 4:25:07 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/18/2017 11:35:53 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/15/2017 12:05:03 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 5/5/2017 4:59:52 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/3/2017 6:06:16 AM
Stocks with Key Influences on the Horizon and New Coverage in the Mobile Tech Space "InvestorsHub NewsWire" - 4/20/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/19/2017 3:00:46 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/17/2017 5:15:25 PM
Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth "InvestorsHub NewsWire" - 4/12/2017 8:49:04 AM
Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth "InvestorsHub NewsWire" - 4/12/2017 8:47:59 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/4/2017 4:19:40 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/31/2017 11:20:52 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/20/2017 4:32:58 PM
Unique Cannabis-Pharma Companies Trailblazing the Medical Cannabis Industry "NetworkNewsWire" - 3/16/2017 9:30:00 AM
Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth "NetworkNewsWire" - 3/15/2017 9:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2017 4:03:55 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/7/2017 6:06:08 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/2/2017 9:15:23 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/26/2017 5:15:05 PM
MMMQA Member Level  Monday, 03/20/17 08:38:14 PM
Re: Belzoni post# 73303
Post # of 98434 




Thats a powerful statement from someone with her background.
Quote:
Dr. Rozenblat is an independent consultant in the field of herbal research and product development for the cosmetics, pharma and raw materials industries. She has over 15 years’ experience in research and development of herbal extracts and products, mainly in the field of dermatology. In the past 8 years, Dr. Rozenblat served as the chief scientist at Kamedis ltd. in Israel, an herbal-based dermatological company, where she had established the R&D department and led the herbal research and the development of herbal-based products for the treatment of different dermatological conditions. She also served as the scientific research director of joint development projects funded by the Korea-Israel Industrial R&D Foundation (KORIL) and Israel-Singapore foundation (SIIRD) resulting in numerous products and patents. In her work in Chengdu, China, she had developed advanced extraction methods and Quality Control methodology. Dr. Rozenblat gives lectures in many dermatology and biotechnology conferences. Dr. Rozenblat earned her doctorate in Biochemistry and Cell Biology from Bar Ilan University in Israel, where her research focused on botanical components as therapeutic agents for melanoma.



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist